Pertuzumab และ Trastuzumab ในมะเร็งเต้านม HER2-Positive ระยะเริ่มเป็น

Trastuzumab - Cancer Precision Medicine trastuzumab

trastuzumab A drug used alone or with other drugs to treat certain types of breast cancer, stomach cancer, and gastroesophageal junction cancer that are HER2

trastuzumab Trastuzumab emtansine is a HER2-targeted, microtubule-stabilizing antibody-drug conjugate with about 3 chemotherapy molecules per antibody Key Message The ShortHER trial failed to demonstrate the non-inferiority of 9 weeks versus 1 year of adjuvant trastuzumab combined with chemotherapy The short Trastuzumab works by binding to HER2, a protein involved in cell growth found in large amounts on some cancer cells This binding blocks the

ลาล่า Comment: Trastuzumab is a humanized IgG1κ monoclonal antibody targeting HER2 Annotated peptide sequences for this antibody are available from its IMGTmAb-DB